FLSmidth to supply cement plant in the Democratic Republic

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
FLSmidth to supply cement plant in the Democratic Republic of Congo

Company Announcement to the Danish Financial Supervisory Authority No. 18-2014, 20 August 2014 FLSmidth has won a contract worth EUR 68m (DKK 507m) from Nyumba Ya Akiba SARL to supply a complete package of equipment and engineering for a greenfield cement plant in the Democratic Republic of Congo. The plant will be located in the province of Bas-Congo, approximately 250 km west of the capital Kinshasa. Nyumba Ya Akiba SARL is a joint venture between Pakistani Lucky Cement Ltd. and the Rawji Group of the Democratic Republic of Congo. The parties are well established players in the cement industry and in the commercial sector of the Democratic Republic of Congo. FLSmidth has earlier only delivered selected equipment to Lucky Cement Ltd. in Pakistan. The equipment to be supplied includes among others FLSmidth crushers, pyro processing equipment and vertical mills for raw meal, coal and cement grinding - all well-proven machinery that is characterised by high productivity, flexibility and energy efficiency. When completed, the cement plant will have a capacity of 3,000 tonnes per day. "In addition to its enormous mineral resources, the Democratic Republic of Congo is characterised by growing stability and a rapidly increasing population. There is therefore an urgent need for cement for development of infrastructure and housing. For the past 40 years no new cement plants have been constructed in the Republic, which is therefore a very interesting market for FLSmidth," President of the Cement Division Per Mejnert Kristensen comments. The order will be booked by the Cement Division and contribute beneficially to FLSmidth's earnings until early 2016.               ------------------------------------- Please address any questions regarding this announcement to President of the Cement Division Per Mejnert Kristensen, FLSmidth & Co. A/S at +45 36 18 18 00. For further information about FLSmidth, please visit www.flsmidth.com. Yours faithfully Pernille Friis Andersen Corporate Communications & Investor Relations [HUG#1850047]

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zenas BioPharma Investors Urged to Join Class Action Lawsuit

Updated Category News Views 119

Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...

Continue Reading
Ayar Labs Raises $155 Million to Transform AI Infrastructure

Updated Category News Views 716

Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...

Continue Reading
Transforming the Non-Profit Sector: The Impact Collaborative

Updated Category News Views 159

Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...

Continue Reading
Synovus Financial Corp Declares Quarterly Dividends for Investors

Updated Category News Views 128

Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...

Continue Reading
Walnut Hill Medical Enhances Patient Access Through FDA TAP Program

Updated Category News Views 171

Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...

Continue Reading